FDA Approves Drug to Help Curb a Tough-to-Treat Prostate Cancer

Posted on


  1. FDA Approves Drug to Help Curb a Tough-to-Treat Prostate Cancer  HealthDay
  2. FDA Approves Apalutamide for Nonmetastatic Prostate Cancer  Medscape
  3. FDA approves J&J prostate cancer treatment  Reuters
  4. Full coverage



, HealthDay News A new drug that can stall the progression of a particularly hard to treat form of prostate cancer has been approved for use by U.S. health officials. In a recent study, the drug called Erleada apalutamide has shown breakthrough effectiveness in keeping prostate cancer from .WEDNESDAY, Feb. , HealthDay News A new drug that can stall the progression of a particularly hard to treat form of prostate cancer has been approved for use by U.S. health officials. In a recent study, the drug called Erleada apalutamide has shown breakthrough effectiveness in keeping .Note Press announcements from are available through the FDA.gov Archive. Some links in press announcements may no longer be active. For more information, contact FDA s Office of Media Affairs at . Email subscription Icon Sign up to receive FDA Press Releases..The U.S. Food and Drug Administration today approved Erleada apalutamide for the treatment of patients with prostate cancer that has not spread non metastatic , but that continues to grow despite treatment with hormone therapy castration resistant . This is the first FDA approved treatment for .







Leave a Reply

Your email address will not be published. Required fields are marked *